Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-20-029756
Date:2020-03-04
Issuer: IMMUNOMEDICS INC (IMMU)
Original Submission Date:

Reporting Person:

MALIK USAMA
C/O IMMUNOMEDICS, INC.
300 THE AMERICAN ROAD MORRIS PLAINS, NJ 07950

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 17.16 2020-03-04 deemed execution date A 61,920 (a) 2027-03-04 common stock, par value $0.01 per share 61,920 $17.16 61,920 direct
Footnotes
IDfootnote
f1 the reporting person was granted stock options pursuant to the issuer's 2014 long-term incentive plan (the "plan"). the stock options vest 25% on the first anniversary of the date of grant, and on a quarterly basis thereafter over a three year period.
WhaleWisdom Logo

Elevate your investments